Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2019 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
The neuropathology of genetic Parkinson's disease.
Poulopoulos M, Levy OA, Alcalay RN. Poulopoulos M, et al. Mov Disord. 2012 Jun;27(7):831-42. doi: 10.1002/mds.24962. Epub 2012 Mar 26. Mov Disord. 2012. PMID: 22451330 Free PMC article. Review.
Pathological data from autopsies genotyped for Parkinson's disease (PD)-related mutations in alpha-synuclein, Parkin, PINK1, DJ1, LRRK2, and glucocerebrosidase have accumulated in recent years. ...Pathological data from DJ1 mutation carriers, nonmanifesting mutation carrie …
Pathological data from autopsies genotyped for Parkinson's disease (PD)-related mutations in alpha-synuclein, Parkin, PINK1, DJ1, LRR …
NPRL3 loss alters neuronal morphology, mTOR localization, cortical lamination and seizure threshold.
Iffland PH, Everett ME, Cobb-Pitstick KM, Bowser LE, Barnes AE, Babus JK, Romanowski AJ, Baybis M, Elziny S, Puffenberger EG, Gonzaga-Jauregui C, Poulopoulos A, Carson VJ, Crino PB. Iffland PH, et al. Brain. 2022 Nov 21;145(11):3872-3885. doi: 10.1093/brain/awac044. Brain. 2022. PMID: 35136953 Free PMC article.
The NPRL3 pedigree exhibited an epilepsy penetrance of 28% and heterogeneous clinical phenotypes with a range of epilepsy semiologies, i.e. focal or generalized onset, brain imaging abnormalities, i.e. polymicrogyria, focal cortical dysplasia or normal imaging, and EEG findings, …
The NPRL3 pedigree exhibited an epilepsy penetrance of 28% and heterogeneous clinical phenotypes with a range of epilepsy semiologies, i.e. …
The natural history of COVID-19 in patients with inflammatory bowel disease: a nationwide study by the Hellenic Society for the study of IBD.
Bamias G, Kokkotis G, Christidou A, Christodoulou DK, Delis V, Diamantopoulou G, Fessatou S, Gatopoulou A, Giouleme O, Kafritsa P, Kalantzis C, Kapsoritakis A, Karatzas P, Karmiris K, Katsanos K, Kevrekidou P, Kosmidis C, Mantaka A, Mathou N, Michalopoulos G, Michopoulos S, Papaconstantinou I, Papatheodoridis G, Polymeros D, Potamianos S, Poulopoulos G, Protopapas A, Sklavaina M, Soufleris K, Theocharis G, Theodoropoulou A, Triantafillidis JK, Triantafyllou K, Tsiolakidou G, Tsironi E, Tzouvala M, Viazis N, Xourgias V, Zacharopoulou E, Zampeli E, Mantzaris GJ. Bamias G, et al. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e810-e817. doi: 10.1097/MEG.0000000000002267. Eur J Gastroenterol Hepatol. 2021. PMID: 34402469 Free PMC article.
Photocatalytic treatment of organic pollutants in a synthetic wastewater using UV light and combinations of TiO2, H2O2 and Fe(III).
Poulopoulos SG, Yerkinova A, Ulykbanova G, Inglezakis VJ. Poulopoulos SG, et al. PLoS One. 2019 May 15;14(5):e0216745. doi: 10.1371/journal.pone.0216745. eCollection 2019. PLoS One. 2019. PMID: 31091256 Free PMC article.
It was shown that the process applied was effective in treating the wastewater for initial total carbon 32 mg L-1, 0.5 g L-1 TiO2, and 66.6 mg L-1 H2O2. Applying UV/TiO2 and UV/H2O2, 58% and 53% total carbon removals were achieved, respectively, but combining TiO2 and H2O2 …
It was shown that the process applied was effective in treating the wastewater for initial total carbon 32 mg L-1, 0.5 g L-1 TiO2, an …
The natural history of the non-nephrotic membranous nephropathy patient.
Hladunewich MA, Troyanov S, Calafati J, Cattran DC; Metropolitan Toronto Glomerulonephritis Registry. Hladunewich MA, et al. Clin J Am Soc Nephrol. 2009 Sep;4(9):1417-22. doi: 10.2215/CJN.01330209. Epub 2009 Aug 6. Clin J Am Soc Nephrol. 2009. PMID: 19661220 Free PMC article.
The only distinguishing baseline feature between the two groups was a higher level of urine protein in the group that subsequently developed nephrotic syndrome (1.98 [0.3 to 3.4] versus 2.43 [0.5 to 3.4] g/d). CONCLUSIONS: Patients with MGN and sustained subnephrotic range …
The only distinguishing baseline feature between the two groups was a higher level of urine protein in the group that subsequently developed …